Companies believe high-level AI policies and frameworks provide audit protection. However, auditors bypass these to demand granular proof for specific AI-assisted decisions, asking for data lineage, model versions, and human decision trails at a precise moment in time, which is where most governance systems fail.
To assess audit-readiness, pick an AI-driven decision from months ago and attempt to reconstruct every detail: data input, model version, validation status, and review trail. If you cannot gather all this information within 48 hours, your governance framework will fail a real-world audit.
The biggest blind spot in AI governance isn't the model but human interaction. Even with a validated tool, systems break when users export data, manipulate it "off-platform," and re-import it. This unmonitored human intervention breaks the chain of traceability, making audit reconstruction impossible.
Just as GXP compliance doesn't require mapping a human's brain, AI governance shouldn't fixate on fully explaining a model's "black box." Instead, it should mimic human compliance by establishing robust frameworks around the model—controlling inputs, outputs, traceability, and guardrails—to ensure trustworthy outcomes.
When procuring AI, pharma companies must prioritize vendors who design governance and traceability into their products from day one. Attempting to add compliance layers to a general-purpose tool after implementation is described as a "nightmare" and is a recipe for failure in a regulated environment.
Contrary to the view that governance slows innovation, a well-implemented "trust by design" framework actually accelerates it. Companies that master operational governance can deploy AI solutions more quickly and confidently, transforming compliance from a brake into a competitive advantage of "speed by design."